Nutritional Supplementation in the Elderly With Weight Loss (Elderly)
Sponsor: University of California, Los Angeles
Terminated
Unable to enroll due to Pandemic
Other terminated trials from University of California, Los Angeles
- Crohn Disease · Phase NA · Mar 2025
- Insomnia · Phase NA · Feb 2024
- Health Care Utilization · Phase NA · Oct 2023
- Cessation, Tobacco · Phase PHASE2 · Jul 2023
- Glaucoma · Phase PHASE4 · Dec 2022
More terminations from University of California, Los Angeles
Other Sarcopenia trials with similar outcome
This NA trial investigates Sarcopenia and is currently terminated or withdrawn. University of California, Los Angeles leads this study, which shows 7 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jun 2023 — Jul 2024 [monthly]
Terminated NA
-
May 2021 — Jun 2023 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
May 2020 — Sep 2020 [monthly]
Recruiting NA
First recorded
Sep 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, Los Angeles
For direct contact, visit the study record on ClinicalTrials.gov .